| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe50d40c086211adb22f28102e071f2c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate |
2003-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164af6b33f4ecf537303e210710e46c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4046024a4ec351a40cf86a3dc391c47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b33804ae4a426b85c62e7451ba38d827 |
| publicationDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004121385-A1 |
| titleOfInvention |
Variants of the human AMP-activated protein kinase gamma 3 subunit |
| abstract |
PRKAG3 nucleotide and amino acid sequence variants and methods of detecting such sequence variants are described. Methods for providing risk estimates for development of a metabolic disease also are described and are based on the presence or absence of PRKAG3 sequence variants in a biological sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10024796-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11536715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11754562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944972-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11092606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10876971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10190151-B2 |
| priorityDate |
2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |